Ran across this piece in the Wall St. Journal the other night. As someone who is at risk from Covid and very interested in avoiding another prolonged recovery, I'm not pleased to see it appears we're giving up on Covid.
It's majority medicine at its finest. Most people will be fine. So 20% collateral damage is fine. Apparently.
We can't save everyone, so we'll save no one. It's cheaper that way.
A pinch of plagicide. You'll barely feel it.
If someone can find a profit in treating Covid patients, cool, but they're on their own (aside from their regularly scheduled government subsidies).
Some snippets:
"The Administration’s response has been to implore doctors to prescribe the antiviral Paxlovid. But many patients at highest risk for Covid can’t take the Pfizer drug because they have medical conditions or take drugs that could cause life-threatening interactions. One study found that half of hospitalized patients who die from Covid have a contraindication with Paxlovid. Some patients can temporarily stop taking other medications, but many can’t or would need to be weaned off them. Doctors could be sued if they prescribe Paxlovid to patients with contraindications who later have complications."
I called this out (not here) over a year ago and it was crickets. Doctors said shit online. There was no analysis. If you looked at the headlines when Paxlovid first came out, you wouldn't know this. You had to dig for it. No one would do the logistics, but I did and I knew it was going to be bullshit.
Our perceptions were managed. Profits were protected. The media was complicit. Politicians wanted to win their re-election campaigns. And corporations wanted all the money.
Those of us who had contraindications which also meant we really really needed protection from Covid, we got nothing.
As it was, as it will always be.
(Side bar: The same dynamics are at play with regards to AI right now. We're all trapped in an episode of Shark Tank.)
No comments:
Post a Comment
Thanks for your comment. I read all comments and do my best to respond to questions, usually in a new post.